Cite
Safety of the Northern Hemisphere 2014/2015 formulation of the inactivated split-virion intramuscular trivalent influenza vaccine
MLA
E. Jeziorski, et al. “Safety of the Northern Hemisphere 2014/2015 Formulation of the Inactivated Split-Virion Intramuscular Trivalent Influenza Vaccine.” Vaccine Reports, vol. 6, Dec. 2016, pp. 1–7. EBSCOhost, https://doi.org/10.1016/j.vacrep.2016.07.001.
APA
E. Jeziorski, M.-P. El Qomri, P. Reix, N. Lavis, C. Petit, V. Houdouin, C. Meyzer, D. Pinquier, François Dubos, D. Plantaz, E. Mothe, E. Merlin, G. Deschenes, & J. Stoller. (2016). Safety of the Northern Hemisphere 2014/2015 formulation of the inactivated split-virion intramuscular trivalent influenza vaccine. Vaccine Reports, 6, 1–7. https://doi.org/10.1016/j.vacrep.2016.07.001
Chicago
E. Jeziorski, M.-P. El Qomri, P. Reix, N. Lavis, C. Petit, V. Houdouin, C. Meyzer, et al. 2016. “Safety of the Northern Hemisphere 2014/2015 Formulation of the Inactivated Split-Virion Intramuscular Trivalent Influenza Vaccine.” Vaccine Reports 6 (December): 1–7. doi:10.1016/j.vacrep.2016.07.001.